692 related articles for article (PubMed ID: 34105304)
41. The Limitations of Standard Clinicopathologic Features to Accurately Risk-Stratify Prognosis after Resection of Intrahepatic Cholangiocarcinoma.
Bagante F; Merath K; Squires MH; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Groot Koerkamp B; Guglielmi A; Itaru E; Pawlik TM
J Gastrointest Surg; 2018 Mar; 22(3):477-485. PubMed ID: 29352440
[TBL] [Abstract][Full Text] [Related]
42. Predicting prognosis in intrahepatic cholangiocarcinoma by the histopathological features.
Liu H; Lan T; Cai YS; Lyu YH; Zhu J; Xie SN; Hu FJ; Liu C; Wu H
Asian J Surg; 2024 Jun; 47(6):2589-2597. PubMed ID: 38604849
[TBL] [Abstract][Full Text] [Related]
43. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
[TBL] [Abstract][Full Text] [Related]
44. Prognostic value and predication model of microvascular invasion in patients with intrahepatic cholangiocarcinoma: a multicenter study from China.
Chen Y; Liu H; Zhang J; Wu Y; Zhou W; Cheng Z; Lou J; Zheng S; Bi X; Wang J; Guo W; Li F; Wang J; Zheng Y; Li J; Cheng S; Zeng Y; Liu J
BMC Cancer; 2021 Dec; 21(1):1299. PubMed ID: 34863147
[TBL] [Abstract][Full Text] [Related]
45. Adjuvant Transarterial Chemoembolization Following Liver Resection for Intrahepatic Cholangiocarcinoma Based on Survival Risk Stratification.
Li J; Wang Q; Lei Z; Wu D; Si A; Wang K; Wan X; Wang Y; Yan Z; Xia Y; Lau WY; Wu M; Shen F
Oncologist; 2015 Jun; 20(6):640-7. PubMed ID: 25956404
[TBL] [Abstract][Full Text] [Related]
46. Prognostic value of combined preoperative fibrinogen-albumin ratio and platelet-lymphocyte ratio score in patients with breast cancer: A prognostic nomogram study.
Zheng Y; Wu C; Yan H; Chen S
Clin Chim Acta; 2020 Jul; 506():110-121. PubMed ID: 32156604
[TBL] [Abstract][Full Text] [Related]
47. Predictors of Distant Metastasis and Prognosis in Newly Diagnosed T1 Intrahepatic Cholangiocarcinoma.
Guo K; Lou Y; Zheng S
Biomed Res Int; 2023; 2023():6638755. PubMed ID: 36704724
[TBL] [Abstract][Full Text] [Related]
48. Clinical Features and Prognostic Models in Patients with Intrahepatic Cholangiocarcinoma: a Population-Based Analysis.
Zhao K; Yang D; Zhou Y; Ding Y
J Gastrointest Surg; 2023 May; 27(5):945-955. PubMed ID: 36729234
[TBL] [Abstract][Full Text] [Related]
49. Survival analysis of patients with extrahepatic cholangiocarcinoma: a nomogram for clinical and MRI features.
Zeng Y; Wang X; Wu J; Wang L; Shi F; Shu J
BMC Med Imaging; 2024 Jan; 24(1):7. PubMed ID: 38166729
[TBL] [Abstract][Full Text] [Related]
50. A novel online calculator to predict recurrence risk in patients with distal cholangiocarcinoma after radical pancreaticoduodenectomy.
Xu S; Zhang XP; Zhao GD; Zou WB; Zhao ZM; Hu MG; Gao YX; Tan XL; Liu Q; Liu R
J Surg Oncol; 2022 Mar; 125(3):377-386. PubMed ID: 34617593
[TBL] [Abstract][Full Text] [Related]
51. Risk stratification system to predict recurrence of intrahepatic cholangiocarcinoma after hepatic resection.
Jeong S; Cheng Q; Huang L; Wang J; Sha M; Tong Y; Xia L; Han L; Xi Z; Zhang J; Kong X; Gu J; Xia Q
BMC Cancer; 2017 Jul; 17(1):464. PubMed ID: 28673346
[TBL] [Abstract][Full Text] [Related]
52. Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels.
Lin ZY; Liang ZX; Zhuang PL; Chen JW; Cao Y; Yan LX; Yun JP; Xie D; Cai MY
BMC Cancer; 2016 Oct; 16(1):792. PubMed ID: 27733196
[TBL] [Abstract][Full Text] [Related]
53. Preoperative risk score for prediction of long-term outcomes after hepatectomy for intrahepatic cholangiocarcinoma: Report of a collaborative, international-based, external validation study.
Brustia R; Langella S; Kawai T; Fonseca GM; Schielke A; Colli F; Resende V; Fleres F; Roulin D; Leyman P; Giacomoni A; Granger B; Fartoux L; De Carlis L; Demartines N; Sommacale D; Sanches MD; Patrono D; Detry O; Herman P; Okumura S; Ferrero A; Scatton O;
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):560-571. PubMed ID: 31718919
[TBL] [Abstract][Full Text] [Related]
54. Development and validation of nomograms to accurately predict risk of recurrence for patients with laryngeal squamous cell carcinoma: Cohort study.
Cui J; Wang L; Tan G; Chen W; He G; Huang H; Chen Z; Yang H; Chen J; Liu G
Int J Surg; 2020 Apr; 76():163-170. PubMed ID: 32173614
[TBL] [Abstract][Full Text] [Related]
55. A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma.
Zhang SW; Zhang NN; Zhu WW; Liu T; Lv JY; Jiang WT; Zhang YM; Song TQ; Zhang L; Xie Y; Zhou YH; Lu W
Front Oncol; 2022; 12():946531. PubMed ID: 35936698
[TBL] [Abstract][Full Text] [Related]
56. Establishment and validation of a prognostic nomogram for patients with resectable perihilar cholangiocarcinoma.
Chen P; Li B; Zhu Y; Chen W; Liu X; Li M; Duan X; Yi B; Wang J; Liu C; Luo X; Li X; Li J; Liang L; Yin X; Wang H; Jiang X
Oncotarget; 2016 Jun; 7(24):37319-37330. PubMed ID: 27144432
[TBL] [Abstract][Full Text] [Related]
57. A novel preoperative inflammation score system established for postoperative prognosis predicting of intrahepatic cholangiocarcinoma.
Fu J; Chen Q; Lai Z; Lin K; Fang G; Ding Z; Gao Y; Zeng Y
BMC Cancer; 2023 Feb; 23(1):188. PubMed ID: 36829168
[TBL] [Abstract][Full Text] [Related]
58. Investigating effects of preoperative inflammatory biomarkers on predicting survival outcomes of intrahepatic cholangiocarcinoma after curative resection.
Zhang Z; Zhou Y; Hu K; Huang Y
World J Surg Oncol; 2020 Oct; 18(1):272. PubMed ID: 33097053
[TBL] [Abstract][Full Text] [Related]
59. Efficacy and safety of adjuvant chemotherapy in T1N0M0 intrahepatic cholangiocarcinoma after radical resection.
Li XH; Zhao CY; Zhou EL; Lin XJ
BMC Cancer; 2022 Nov; 22(1):1159. PubMed ID: 36357848
[TBL] [Abstract][Full Text] [Related]
60. Nomograms for predicting overall survival and cancer-specific survival in patients with surgically resected intrahepatic cholangiocarcinoma.
Ma K; Dong B; Wang L; Zhao C; Fu Z; Che C; Liu W; Yang Z; Liang R
Cancer Manag Res; 2019; 11():6907-6929. PubMed ID: 31440084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
